Moneylion Insider Sold Shares Worth $641,440, According to a Recent SEC Filing-March 2024-www.financetom.com

Moneylion Insider Sold Shares Worth $641,440, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Moneylion Insider Sold Shares Worth $641,440, According to a Recent SEC Filing

Nov 9, 2024 1:38 PM

05:48 PM EST, 11/08/2024 (MT Newswires) -- Richard Correia, President, CFO and Treasurer, on November 07, 2024, sold 9,342 shares in Moneylion ( ML ) for $641,440. Following the Form 4 filing with the SEC, Correia has control over a total of 209,845 shares of the company, with 209,845 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1807846/000121390024096014/xslF345X05/ownership.xml

Previous page： Sector Update: Consumer Stocks Mixed Premarket Wednesday Next page： UBS Comments on Israel's Central Bank, Economy, Shekel

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sector Update: Consumer Stocks Mixed Premarket Wednesday

Aug 29, 2024

09:15 AM EDT, 08/28/2024 (MT Newswires) -- Consumer stocks were mixed premarket Wednesday with the Consumer Staples Select Sector SPDR Fund ( XLP ) 0.2% higher and the Consumer Discretionary Select Sector SPDR Fund ( XLY ) down 0.1% recently. Foot Locker ( FL ) shares fell past 8% after it reported a fiscal Q2 adjusted loss of $0.05 per...

UBS Comments on Israel's Central Bank, Economy, Shekel

Aug 29, 2024

09:18 AM EDT, 08/28/2024 (MT Newswires) -- The Bank of Israel (BoI) is likely to keep its policy rate on hold at 4.50% in the coming months, as inflation has moved above the 3% target again -- in July it was 3.2% y/y-- and risks from the war to the budget and shekel (ILS) remain significant, said UBS. Economic growth...

Allurion Technologies Says Data From Study Show Improved Weight Reduction in Participants of Weight Loss Program After 1 Year

Aug 29, 2024

09:17 AM EDT, 08/28/2024 (MT Newswires) -- Allurion Technologies ( ALUR ) said Wednesday that data from a study of patients participating in its medical weight loss program showed a 10.5% average weight reduction after four months, improving to 13.7% after a year. The company said the study involved 486 patients who were treated with the Allurion Balloon and asserted...

Azitra Doses First Patient in ATR-12 Study for Rare Skin Disorder

Aug 29, 2024

09:07 AM EDT, 08/28/2024 (MT Newswires) -- Azitra ( AZTR ) said Wednesday that it has dosed the first patient in a phase 1b clinical study of its lead drug candidate, ATR-12, for the potential treatment of Netherton syndrome, a rare genetic skin disorder. The company said the trial will include about 12 adult patients, who will receive twice-daily treatments...